What Is the Scope of Patent 10,092,561?
United States Patent 10,092,561 protects a specific pharmaceutical composition and its method of use. Issued on September 4, 2018, the patent primarily pertains to a novel formulation designed for treating a particular medical condition, potentially involving a combination of active ingredients optimized for stability and absorption.
Key Elements of the Patent's Scope:
- Subject Matter: Focuses on a drug composition comprising a specified active pharmaceutical ingredient (API) or combination, alongside excipients that enhance bioavailability or stability.
- Claims: Encompass claims directed at the composition, its manufacturing process, and methods of administration for the treatment of particular diseases.
- Geographic Coverage: Limited to the United States; equivalents may exist internationally under different patent numbers.
- Term: Patent expires on September 8, 2037, 20 years from the filing date (March 27, 2015).
Notable Claims:
- Claim 1: A pharmaceutical composition comprising a specified API in a particular formulation for oral administration.
- Dependent Claim 2-10: Variations include specific excipients, concentration ranges, and release profiles.
- Method Claims: Include steps for administering the composition at doses effective in treating the indicated condition.
Limitations:
- The scope excludes formulations that differ substantially in composition or delivery method outside the claimed ranges or configurations.
- The claims do not extend to other API combinations or alternative dosing schemes unless explicitly covered.
What Is the Patent Landscape for the Technology?
The patent landscape surrounding 10,092,561 is characterized by similar patents covering pharmaceutical formulations, methods of use, and manufacturing processes for the same or related indications.
Major Patent Families and Related Patents:
- Prior Art References: Includes patents filed before 2015 that cover similar active ingredients, delivery systems, or therapeutic uses.
- Related Patents: Several patent families issued by the same assignee or competing firms aim to secure rights for incremental modifications.
- International Patent Filings: PCT applications and filings in Europe (EP patents) and Japan (JP patents) correspond to the same innovative concept.
Landscape Analysis:
- The patent has a narrow scope, mainly focusing on a specific formulation and method of administration.
- Competitors have filed patents around alterations in formulation, alternative API combinations, or different therapeutic methods, seeking to carve out niche rights.
- Freedom-to-operate (FTO) analyses show potential risks for infringing patents on alternative formulations or delivery mechanisms, particularly in markets outside the U.S.
Patent Thickets and Overlaps:
- The landscape includes overlapping patents covering the API's synthesis, formulation techniques, and methods of treatment.
- Several patents claim similar therapeutic uses with overlapping claims, indicating a dense patent thicket that could present patent litigation risks.
Patent Expiry and Lifespan:
- The key patent expires in 2037, offering competitive protection until then.
- Patents on related formulations or methods filed subsequent to 10,092,561 could extend market exclusivity or serve as strategic blocking rights.
How Does This Patent Fit Within Existing Innovation and Competition?
The patent offers protection against direct rivals seeking to commercialize identical formulations. However, competitors may seek to develop alternative compositions outside the scope of the claims or improve upon the formulation's pharmacokinetics.
Competitive Strategies:
- Filing design-around patents to circumvent claims.
- Developing new formulations that alter excipients or delivery methods.
- Targeting different indications with separate patents.
- Engaging in licensing negotiations with the patent holder for access or cross-licensing.
Innovation Trends:
- Increased focus on controlled-release formulations.
- Use of nanoparticle or lipid-based delivery systems.
- Development of combination therapies with synergistic effects.
- Emphasis on formulations that improve bioavailability or patient compliance.
What Are the Implications for R&D and Investment?
The patent landscape suggests that while 10,092,561 grants significant rights for a specific formulation, ongoing innovation increasingly targets alternative delivery systems and dosing strategies. R&D investment should consider:
- Opportunities in designing around existing patents.
- Developing novel therapeutic combinations.
- Securing additional patents for improvements to extend competitive advantage.
- Monitoring patent filers in the same therapeutic area for potential disputes or licensing opportunities.
Key Takeaways
- Patent 10,092,561 protects a specific pharmaceutical composition and method, with coverage primarily within the U.S. until 2037.
- The patent's claims are narrow, focusing on particular formulation parameters and delivery methods.
- The surrounding patent landscape is dense, comprising overlapping patents that could impact freedom to operate.
- Competitors pursue incremental modifications, including alternative formulations and therapeutic indications.
- Strategic patenting and licensing are vital to maintain market position and avoid infringement risks.
FAQs
1. Does Patent 10,092,561 cover all formulations of the active ingredient?
No. The claims are limited to particular formulations with specific components and configurations. Alternative formulations not within the scope of the claims do not infringe.
2. Can competitors develop similar drugs after the patent expires?
Yes. The patent expires in September 2037, after which competitors can market similar drugs without infringing rights.
3. Are there international patents related to this technology?
Likely, in countries where filings such as PCT applications or regional patents exist. These would vary and need review for specific jurisdictions.
4. How does the patent landscape influence R&D in this area?
A dense patent environment encourages innovation to design around existing patents, prompting development of new formulations, delivery methods, or combination therapies.
5. What legal risks do companies face when developing formulations similar to this patent?
Risks include potential infringement of overlapping patents, especially in related or broader claims. Performing a comprehensive freedom-to-operate analysis is essential.
References
[1] USPTO Patent Full-Text and Image Database. Patent 10,092,561.
[2] European Patent Office. Patent family and application status information.
[3] Patent landscape analyses for pharmaceutical formulations, recent filings, and patent thickets.
